Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resistance Training and 1,25 (OH)2D3 Administration to Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

NCT03469271 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03469271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03469271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resistance Training and 1,25 (OH)2D3 Administration to Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Completed
Start date
May 25, 2018
Completion date
May 21, 2020
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer